Alopecia Areata: Clinical Trials

12 trials for Alopecia Areata, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 12

Follow Alopecia Areata: new trials by email Literature Review of Alopecia Areata trials Research Report on Alopecia Areata

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata
Roflumilast, intralesional steroid - Alopecia, Alopecia Areata
Phase 4CompletedCairo University502025-01-122025-09-15
Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.
Apremilast 30mg - Alopecia Areata
Phase 4CompletedJinnah Postgraduate Medical Centre302022-08-012023-07-03
Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
Tofacitinib - Alopecia Areata
Phase 4CompletedInstitute of Dermatology, Thailand192019-01-122022-03-31
Pain Outcomes Following Intralesional Corticosteroid Injections
Corticosteroid with lidocaine, Corticosteroid with normal saline - Keloid, Alopecia Areata
Phase 4CompletedVanderbilt University Medical Center312018-10-012021-03-11
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
Triamcinolone Acetonide, Minoxidil 5 % Topical Spray, clobetasol propionate - Alopecia Areata
Phase 4CompletedCairo University402016-03-012018-05-24
Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata
Topical latanoprost 0.005%, Topical betamethasone 0.05% - Alopecia Areata
Phase 4CompletedPost Graduate Institute of Medical Education and Research, Chandigarh502014-09-012015-12-02
Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children
bimatoprost ophthalmic solution 0.03%, Vehicle Sterile Solution - Eyelash Hypotrichosis, Alopecia Areata
Phase 4CompletedAllergan712010-06-012019-04-17
Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
methylprednisolone sodium succinate - Alopecia Totalis, Alopecia Universalis
Phase 4CompletedKing Saud University422003-01-012010-07-22
Plaquenil for Alopecia Areata, Alopecia Totalis
Hydroxychloroquine - Alopecia Areata
Phase 4CompletedHordinsky, Maria K., MD162002-04-012009-08-13
Aldara for the Treatment of Extensive Alopecia Areata
Aldara Cream 5% - Alopecia Areata
Phase 4CompletedHordinsky, Maria K., MD202000-10-012006-11-13
Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%
Aldara Cream 5% - Alopecia Areata
Phase 4CompletedHordinsky, Maria K., MD202000-10-012014-02-14
Response of Topical Capsaicin in Alopecia Areata
Capsaicin - Alopecia Areata
Phase 4CompletedUniversity of Minnesota241997-08-012014-06-02

Narrower conditions

Alopecia universalis (2)  ·  Acne Vulgaris (1)  ·  Alopecia (1)  ·  Cicatrix, Hypertrophic (1)  ·  Dermoid Cyst (1)  ·  Granuloma Annulare (1)  ·  Keloid (1)  ·  Keratoacanthoma (1)  ·  Lichen Planus (1)  ·  Neurodermatitis (1)  ·  Scleroderma, Localized (1)

Broader conditions

Hair Diseases (12)  ·  Hypotrichosis (12)  ·  Skin Diseases (12)  ·  Skin and Connective Tissue Diseases (12)  ·  Alopecia (11)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Acneiform Eruptions (1)  ·  Cicatrix (1)  ·  Collagen Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Cysts (1)  ·  Dermatitis (1)  ·  Fibrosis (1)  ·  Granuloma (1)  ·  Lichenoid Eruptions (1)

Interventions

Adrenal Cortex Hormones (1)  ·  Bimatoprost (1)  ·  Capsaicin (1)  ·  Clobetasol (1)  ·  Hydroxychloroquine (1)  ·  Lidocaine (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Minoxidil (1)  ·  Roflumilast (1)  ·  Saline Solution (1)  ·  Triamcinolone Acetonide (1)  ·  apremilast (1)  ·  tofacitinib (1)

Sponsors

Hordinsky, Maria K., MD (3)  ·  Cairo University (2)  ·  Allergan (1)  ·  Institute of Dermatology, Thailand (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  King Saud University (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  University of Minnesota (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (6)  ·  Brazil (1)  ·  Egypt (1)  ·  India (1)  ·  Pakistan (1)  ·  Saudi Arabia (1)  ·  Thailand (1)

Top investigators

Maria Hordinsky, MD (4)  ·  Marna Ericson, Ph D (2)  ·  Brian Drolet, MD (1)  ·  Chinmanat Lekhavat, MD (1)  ·  Faiza Inam, FCPS (1)  ·  Ghada A Binsaif, MD (1)  ·  Heba M Mashaly, MD (1)  ·  Khadija Asadullah, FCPS (1)  ·  Marna Ericson, PhD (1)  ·  Mona MI ElKalioby, MD (1)  ·  Nazia Jabeen, FCPS (1)  ·  Nermine H El-Eishi, MD (1)  ·  Olfat G Shaker, MD (1)  ·  Rania M Abdel-Hay, MD (1)

Results publications

PMID 20115945, PMID 33580923, PMID 33760691